Search

Oxford Biomedica PLC

Closed

299 0.84

Overview

Share price change

24h

Current

Min

285.5

Max

300

Key metrics

By Trading Economics

Income

-32M

Sales

51M

Profit margin

-63.939

Employees

861

EBITDA

-20M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+118.42% upside

Market Stats

By TradingEconomics

Market Cap

317M

Previous open

298.16

Previous close

299

Oxford Biomedica PLC Chart

Past performance is not a reliable indicator of future results.

Related News

23 Apr 2025, 23:54 UTC

Hot Stocks

Stocks to Watch: International Business Machines, Southwest Airlines, Robert Half

23 Apr 2025, 23:23 UTC

Top News
Earnings

SK Hynix Posts Strong First Quarter Earnings on AI Chip Demand

23 Apr 2025, 21:06 UTC

Earnings

Lam Research Notches Higher 3Q Profit and Revenue, Optimistic 4Q Outlook

23 Apr 2025, 21:03 UTC

Earnings

Texas Instruments Posts Increase in 1Q Sales, EPS

24 Apr 2025, 00:00 UTC

Earnings

Renesas Electronics 1Q Net Y26.01B Vs Net Y79.87B

24 Apr 2025, 00:00 UTC

Earnings

Renesas Electronics 1Q Net Y26.01B Vs Net Y79.87B

23 Apr 2025, 23:47 UTC

Market Talk

Gold Rises Amid Lingering Uncertainty Over U.S.-China Trade War -- Market Talk

23 Apr 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Fears About U.S. Tariffs Ease -- Market Talk

23 Apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

23 Apr 2025, 23:37 UTC

Market Talk

Global Energy Roundup: Market Talk

23 Apr 2025, 23:36 UTC

Market Talk

Fed Should Have a 'High Bar' to Intervene in Markets, Hammack Says -- Market Talk

23 Apr 2025, 23:21 UTC

Market Talk

Northern Star Bull Says Share Price Accounts for Operational Risks -- Market Talk

23 Apr 2025, 23:00 UTC

Top News

South Korea's Economy Shrinks in 1Q Before Trump Tariffs Hit

23 Apr 2025, 22:51 UTC

Earnings

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

23 Apr 2025, 22:50 UTC

Earnings

SK Hynix 1Q Net KRW8.108T Vs. Net KRW1.917T >000660.SE

23 Apr 2025, 22:49 UTC

Earnings

SK Hynix 1Q Oper Pft KRW7.441T Vs. Pft KRW2.886T >000660.SE

23 Apr 2025, 22:49 UTC

Earnings

SK Hynix 1Q Rev KRW17.639T Vs. KRW12.430T >000660.SE

23 Apr 2025, 22:32 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Energy Roundup: Market Talk

23 Apr 2025, 22:32 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Woodside Appears Cornered Into 2Q Decision on Louisiana LNG -- Market Talk

23 Apr 2025, 22:29 UTC

Market Talk
Earnings

ServiceNow CEO Says Aptiv Deal Marks 2nd Largest in EMEA -- Market Talk

23 Apr 2025, 22:18 UTC

Earnings

CGN Power: 1Q Net Weighed by Fall in Electricity Prices, Higher R&D Expenses >1816.HK

23 Apr 2025, 22:17 UTC

Earnings

CGN Power 1Q Net CNY3.03B Vs. Net CNY3.60B >1816.HK

23 Apr 2025, 22:17 UTC

Earnings

CGN Power 1Q Rev CNY20.03B Vs. CNY19.18B >1816.HK

23 Apr 2025, 21:57 UTC

Market Talk
Earnings

ServiceNow Earnings, Guidance Soothe Fear of Slower Govt Business -- Market Talk

23 Apr 2025, 21:48 UTC

Top News

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 Apr 2025, 21:14 UTC

Top News
Earnings

Southwest Airlines Drops Forecast as Leisure Travelers Pull Back -- WSJ

23 Apr 2025, 21:05 UTC

Earnings

Texas Instruments Reports Strong Earnings. The Stock Is Rising but Tariffs Are Still a Risk. -- Barrons.com

23 Apr 2025, 21:02 UTC

Top News

Huge Stock Swings Are the New Normal for Frazzled Investors -- WSJ

23 Apr 2025, 20:51 UTC

Earnings

Boeing Stock Surges on Earnings. There Is Still a Lot of Uncertainty Ahead. -- Barrons.com

23 Apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

Oxford Biomedica PLC Forecast

Price Target

By TipRanks

118.42% upside

12 Months Forecast

Average 649.792 GBX  118.42%

High 800 GBX

Low 500 GBX

Based on 2 Wall Street analysts offering 12 month price targets forOxford Biomedica PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.